This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Feucht, H. H. Articles by Laufs, R. Search for Related Content PubMed PubMed Citation Articles by Feucht, H. H. Articles by Laufs, R.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, Mar 1995, 620-624, Vol 33, No. 3
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Study on reliability of commercially available hepatitis C virus antibody tests

HH Feucht, B Zollner, S Polywka and R Laufs
Institute for Medical Microbiology and Immunology, Universitats- Krankenhaus Eppendorf, Hamburg, Germany.

The serodiagnosis of hepatitis C virus (HCV) infection was analyzed by a recombinant immunoblot assay (RIBA) with recombinant proteins encoded by the viral RNA isolated from our patients in Hamburg, Germany. The HCV RNA was amplified by PCR, and proteins encoded by the viral core and the NS3, NS4, and NS5 regions were expressed subsequently in Escherichia coli. The results obtained with our UKE RIBA were compared with the results of the Abbott HCV second-generation enzyme immunoassay (EIA). Serum samples from 270 patients, which were sent to us on the suspicion of HCV hepatitis and which were negative for hepatitis A virus and hepatitis B virus antibodies, were examined. In 227 cases (84.1%), there were identical positive (204 cases, 75.6%) or negative (23 cases, 8.5%) results in both tests. In 32 cases (11.9%), the reactive Abbott second-generation HCV EIA results could not be confirmed by the UKE RIBA and the HCV PCR. In follow-up studies conducted over 1 year, these results did not change. In three cases (1.1%), the UKE RIBA presented a positive result while the Abbott second-generation HCV EIA was negative. All three cases were positive in the HCV PCR and showed seroconversion in an HCV EIA 4 to 6 weeks later. In addition, 33 patient serum samples were examined by UKE RIBA in parallel with the Ortho RIBA 2.0. In three cases (9.1%), a positive Ortho RIBA 2.0 result could not be confirmed by the UKE RIBA and the HCV PCR. All three patients were free of complaints. The UKE RIBA showed also a smaller number of indeterminate results (3.0%) than the Ortho RIBA 2.0 (24.2%). This comparison study demonstrates that the commercially available HCV antibody tests should be further improved.

This article has been cited by other articles:

• Polywka, S., Schröter, M., Feucht, H.-H., Zöllner, B., Laufs, R. (2001). Relevance of Reactivity in Commercially Available Hepatitis C Virus Antibody Assays. J. Clin. Microbiol. 39: 1665-1668 [Abstract] [Full Text]  
• Schröter, M., Polywka, S., Zöllner, B., Schäfer, P., Laufs, R., Feucht, H.-H. (2000). Detection of TT Virus DNA and GB Virus Type C/Hepatitis G Virus RNA in Serum and Breast Milk: Determination of Mother-to-Child Transmission. J. Clin. Microbiol. 38: 745-747 [Abstract] [Full Text]  
• Borowski, P., zur Wiesch, J. S., Resch, K., Feucht, H., Laufs, R., Schmitz, H. (1999). Protein Kinase C Recognizes the Protein Kinase A-binding Motif of Nonstructural Protein 3 of Hepatitis C Virus. J. Biol. Chem. 274: 30722-30728 [Abstract] [Full Text]  
• Schröter, M., Feucht, H.-H., Schäfer, P., Zöllner, B., Laufs, R. (1999). Serological Determination of Hepatitis C Virus Subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a Recombinant Immunoblot Assay. J. Clin. Microbiol. 37: 2576-2580 [Abstract] [Full Text]  
• Mack, D., Riedewald, J., Rohde, H., Magnus, T., Feucht, H. H., Elsner, H.-A., Laufs, R., Rupp, M. E. (1999). Essential Functional Role of the Polysaccharide Intercellular Adhesin of Staphylococcus epidermidis in Hemagglutination. Infect. Immun. 67: 1004-1008 [Abstract] [Full Text]  
• Schröter, M., Feucht, H.-H., Schäfer, P., Zöllner, B., Polywka, S., Laufs, R. (1999). Definition of False-Positive Reactions in Screening for Hepatitis C Virus Antibodies. J. Clin. Microbiol. 37: 233-234 [Abstract] [Full Text]